Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma

British Journal of Ophthalmology

Volumn 88, Issue 12, 2004, Pages 1521-1526

  Krishnakumar, Subramanian ^a   Mallikarjuna, K ^a   Desai, N ^b   Muthialu, A ^c   Venkatesan, N ^a   Sundaram, A ^a   Khetan, V ^d   Shanmugam, M P ^d  

^a VISION RESEARCH FOUNDATION   (India)

^b BROWN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d MEDICAL RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; GLYCOPROTEIN P; LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; VINCRISTINE;

ARTICLE; BONE MARROW METASTASIS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CHILD; CHOROID; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; OPTIC NERVE; ORBIT; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RETINOBLASTOMA; SEMIQUANTITATIVE ANALYSIS; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

BONE MARROW NEOPLASMS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; RETINAL NEOPLASMS; RETINOBLASTOMA; TREATMENT OUTCOME; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 9644295542     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2004.047928     Document Type: Article

References (22)

1. Rodriguez-Galindo C, Wilson MW, Haik BG, et al. Treatment of metastatic retinoblastoma. Ophthalmology 2003;110:1237-40.
2. Chan HS, Thorner PS, Haddad G, et al. Multidrug-resistant phenotype in retinoblastoma correlates with P-glycoprotein expression. Ophthalmology 1991;98:1425-31.
3. Chan HS, Canton MD, Gallie BL Chemosensitivity and multidrug resistant to antineoplastic drugs in retinoblastoma cell lines. Anticancer Res 1989;9:469-74.
4. Chan HS, Thorner PS, Haddad G, et al. Effect of chemotherapy on intraocular retinoblastoma. Int J Pediatr Hematol Oncol 1995;2:269-81.
5. Chan HS, Lu Y, Grogan TM, et al. Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein. Cancer Res 1997;57:2325-30.
6. Gallie BL, Budning A, DeBoer G, et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol. 1996;114:1321-8, Erratum in: Arch Ophthalmol, 1997;115:525.
7. Gallie BL, Budning A, DeBoer G, et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol. 1996;114:1321-8, Erratum in: Arch Ophthalmol, 1997;115:525.
8. Chan HS, DeBoer G, Thiessen JJ, et al. Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin Cancer Res 1996;2:1499-508.
9. Shields CL, De Potter P, Himelstein BP, et al. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 1996; 114:1330-8.
10. Friedman DL, Himelstein B, Shields CL, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 2000;18:12-17.
11. Murphree L, Villablanca JG, Deegan WF 3rd, et al. hemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 1996;114:1348-56.
12. Greenwald MJ, Strauss LC. Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy. Ophthalmology 1996;103:1989-97.
13. Gerlach JH, Kartner N, Bell DR, et al. Multidrug resistance. Cancer Surv 1986;5:25-46.
14. Scheper RJ, Broxterman HJ, Scheffer GL, et al. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 1993;53:1475-9.
15. Scheffer GL, Wijngaard PL, Flens MJ, et al. The drug resistance-related protein LRP is the human major vault protein. Nat Med 1995;1:578-82.
16. Zurita AJ, Diestra JE, Condom E, et al. Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumors. Br J Cancer 2003;88:879-86.
17. Finger PT, Harbour JW, Karcioglu ZA. Risk factors for metastasis in retinoblastoma. Surv Ophthalmol 2002;47:1-16.
18. Liu J, Tang L, Liu X, et al. A gene study on multidrug resistance of retinoblastoma. Zhonghua Yan Ke Za Zhi 2001;37.
19. Fisher GA, Sikic BI. Drug resistance in clinical oncology and hematology. Introduction. Hematol Oncol Clin North Am 1995;9:xi-xii.
20. Duhem C, Ries F, Dicato M. What does multidrug resistance (MDR) expression mean in the clinic? Oncologist 1996;1:151-8.
21. Duvvuri S, Gandhi MD, Mitra AK. Effect of P-glycoprotein on the ocular disposition of a model substrate, quinidine. Curr Eye Res 2003;27:345-53.
22. Pinedo HM, Giaccone G. P-glycoprotein - a marker of cancer cell behavior. N Engl J Med 1995;333:1417-19.